Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
Subscribe to see Pathos AI, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Pathos AI, Inc. is an ai/ml company headquartered in United States. Its most recent funding round, Series D, raised $365M in May 2025. Xcout tracks 33 named people at Pathos AI, Inc., including Iker Huerga (CEO). Xcout recorded 4 job postings from Pathos AI, Inc. in the last 90 days.
27 more named people on record for Pathos AI, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series D | $365M | — | |
| SEC Form D filing | $62M | — | |
| Series C | $62M | 1 named | |
| SEC Form D filing | $20M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 4 job postings from Pathos AI, Inc. in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Pathos AI, Inc.'s hiring signals →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.